RxDoctor Payments Data

Mimi Sato-Re, MD

Family Medicine · Sacramento, CANPI 1649372921

Payments from drug & device makers

$1,055in general payments, 2019–2025

Across 52 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$562
  • Pfizer$117
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$106
  • Sanofi Pasteur Inc.$67
  • Intra-sana Laboratories$50
  • Lilly USA, LLC$30
  • plus $123 from 7 others

What the payments were for

  • Food & beverage$1,055100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,055 in reported general payments places this provider in the 75th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$61,535
Medicare patients
85
Services billed
3,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$11,482
SynthroidLevothyroxine Sodium57$3,581
ProgesteroneProgesterone, Micronized14$1,350
Levothyroxine Sodium96$1,267
Venlafaxine Hcl ErVenlafaxine Hcl15$1,120
Liothyronine Sodium39$1,078
Estradiol21$1,055
Testosterone Cypionate34$1,051
Ibandronate Sodium43$983
Armour ThyroidThyroid,pork13$944
Celecoxib38$912
Rosuvastatin Calcium57$896
Atorvastatin Calcium113$740
Solifenacin Succinate11$635
Np ThyroidThyroid,pork15$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$117$11,48217 claims
AbbVieSynthroid, Armour Thyroid$562$4,52570 claims
Acella Pharmaceuticals, LLCNp Thyroid$13$62715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,533 family medicine providers in California.

Other family medicine in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →